Tag: access to medicines
In advance of the September 2024 WHO pandemic negotiations (INB 11), Knowledge Ecology International (KEI), Innovarte, and Medicines Law & Policy (ML&P) will convene a virtual panel entitled, “Reflections on the IP & Technology Transfer provisions of the WHO...
We invite you to read the following article on the importance of transparency in the costs of medicines and health products, which the WHO has made official through a resolution calling for greater transparency in the pharmaceutical sector, urging...
On 21 May 2024, Wemos, together with KEI, Health Action International (HAI), Innovarte, Medicines Law & Policy, UAEM and Afya na Haki, organized an informative webinar on the eve of the 77th World Health Assembly on the latest and...
We share an interesting article from Innovarte ONG, written by Adán González, about licenses of right, a type of voluntary licenses established in some European countries such as Spain and Germany (art. 87 and following of Law 24/2015, of...
We share an interesting article from Innovarte ONG, which reflects on how the negotiations of the Pandemic Treaty have been diluting the principles of equity and human rights that were sought at the beginning of this process, and how...
